Sporos Bioventures is a Houston-based venture capital firm and private biotechnology company using a portfolio approach to transform oncology drug development. It backs biotechnology, life sciences, oncology and pharmaceutical companies in the United States, has acted as a lead investor at Series A, and has participated in Series B financings, making it relevant for early and later-stage biopharma fundraising.